Get started
agilon health, inc.agilon health, inc.agilon health, inc.

agilon health, inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

AGL chart


Full chart

Key facts today

Citigroup has upgraded Agilon Health from a 'Sell' rating to 'Neutral' and raised the price target from $1.75 per share to $2.25 per share.
Analyze the impactAnalyze the impact

AGL upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.00 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.82 USD
Net income (FY)
‪−215.05 M‬ USD
Revenue (FY)
‪4.32 B‬ USD
Shares float
‪303.29 M‬
Beta (1Y)
−1.03

Employees


Employees (FY)
‪1.12 K‬
Change (1Y)
+370 +49.53%
Revenue / Employee (1Y)
‪3.86 M‬ USD
Net income / Employee (1Y)
‪−174.62 K‬ USD

About agilon health, inc.


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Steven J. Sell
Website
agilonhealth.com
Headquarters
Austin
Founded
2016
FIGI
BBG00HCYVQQ4
Agilon Health, Inc. engages in providing healthcare services. It also provides the technology, people, capital, process, and access to a peer network of primary care physicians. The company was founded by Ronald A. Williams and Veeral Desai in 2016 and is headquartered in Austin, TX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

AGL news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of AGL is 2.43 USD — it has increased by 10.96% in the past 24 hours. Watch agilon health, inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange agilon health, inc. stocks are traded under the ticker AGL.
AGL stock has risen by 25.91% compared to the previous week, the month change is a 17.39% rise, over the last year agilon health, inc. has showed a −69.51% decrease.
We've gathered analysts' opinions on agilon health, inc. future price: according to them, AGL price has a max estimate of 6.00 USD and a min estimate of 2.00 USD. Watch AGL chart and read a more detailed agilon health, inc. stock forecast: see what analysts think of agilon health, inc. and suggest that you do with its stocks.
AGL reached its all-time high on Jun 18, 2021 with the price of 44.83 USD, and its all-time low was 1.50 USD and was reached on Nov 18, 2024. View more price dynamics on AGL chart.
See other stocks reaching their highest and lowest prices.
AGL stock is 19.31% volatile and has beta coefficient of −1.03. Track agilon health, inc. stock price on the chart and check out the list of the most volatile stocks — is agilon health, inc. there?
Today agilon health, inc. has the market capitalization of ‪1.00 B‬, it has decreased by −2.05% over the last week.
Yes, you can track agilon health, inc. financials in yearly and quarterly reports right on TradingView.
agilon health, inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
AGL earnings for the last quarter are −0.29 USD per share, whereas the estimation was −0.10 USD resulting in a −194.15% surprise. The estimated earnings for the next quarter are −0.22 USD per share. See more details about agilon health, inc. earnings.
agilon health, inc. revenue for the last quarter amounts to ‪1.45 B‬ USD, despite the estimated figure of ‪1.47 B‬ USD. In the next quarter, revenue is expected to reach ‪1.52 B‬ USD.
AGL net income for the last quarter is ‪−116.43 M‬ USD, while the quarter before that showed ‪−30.68 M‬ USD of net income which accounts for −279.48% change. Track more agilon health, inc. financial stats to get the full picture.
No, AGL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 12, 2025, the company has ‪1.12 K‬ employees. See our rating of the largest employees — is agilon health, inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. agilon health, inc. EBITDA is ‪−320.89 M‬ USD, and current EBITDA margin is −4.91%. See more stats in agilon health, inc. financial statements.
Like other stocks, AGL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade agilon health, inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So agilon health, inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating agilon health, inc. stock shows the sell signal. See more of agilon health, inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.